Factors influencing pharmacological treatment in COPD: a comparison of 2005 and 2014

References

• Global Initiative for Chronic Obstructive Lung Disease . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [ cited 2017]. Available from: http://www.goldcopd.com.
   Google Scholar
• Jones PW , Harding G , Berry P , et al. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3): 1–10. Epub 2009/ 09/02. doi: 10.1183/09031936.00102509. PubMed PMID: 19720809.
   Web of Science ®Google Scholar
• van der Molen T , Willemse BW , Schokker S , et al. Development, validity and responsiveness of the clinical COPD Questionnaire. Health Qual Life Outcomes. 2003;1: 13. Epub 2003/ 05/30. PubMed PMID: 12773199; PubMed Central PMCID: PMC156640.
   PubMedGoogle Scholar
• Bestall JC , Paul EA , Garrod R , et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7): 581–586. Epub 1999/ 06/22. PubMed PMID: 10377201; PubMed Central PMCID: PMCPMC1745516.
   PubMed Web of Science ®Google Scholar
• Barr RG , Bourbeau J , Camargo CA , et al. Inhaled tiotropium for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2005;2:CD002876. Epub 2005/04/23. doi: 10.1002/14651858.CD002876. PubMed PMID: 15846642.
   Google Scholar
• Geake JB , Dabscheck EJ , Wood-Baker R , et al. Indacaterol, a once-daily beta2-agonist, versus twice-daily beta(2)-agonists or placebo for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;1:CD010139. Epub 2015/01/13. doi: 10.1002/14651858.CD010139. PubMed PMID: 25575340.
   Web of Science ®Google Scholar
• Calverley PM , Anderson JA , Celli B , et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356(8):775–789. Epub 2007/ 02/23. doi: 10.1056/NEJMoa063070. PubMed PMID: 17314337.
   PubMed Web of Science ®Google Scholar
• Welte T , Miravitlles M , Hernandez P , et al. Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180(8):741–750. Epub 2009/ 08/01. doi: 10.1164/rccm.200904-0492OC. PubMed PMID: 19644045.
   PubMed Web of Science ®Google Scholar
• Di Martino M , Agabiti N , Bauleo L , et al. Use patterns of long-acting bronchodilators in routine COPD care: the OUTPUL study. Copd. 2014;11(4):414–423. Epub 2013/ 10/05. doi: 10.3109/15412555.2013.839646. PubMed PMID: 24090036.
   PubMedGoogle Scholar
• Diette GB , Dalal AA , D’Souza AO , et al. Treatment patterns of chronic obstructive pulmonary disease in employed adults in the USA. Int J Chron Obstruct Pulmon Dis. 2015;10: 415–422. Epub 2015/ 03/12. doi: 10.2147/copd.s75034. PubMed PMID: 25759574; PubMed Central PMCID: PMCPMC4346014.
   PubMed Web of Science ®Google Scholar
• Ford ES , Mannino DM , Wheaton AG , et al. Trends in the use, sociodemographic correlates, and undertreatment of prescription medications for chronic obstructive pulmonary disease among adults with chronic obstructive pulmonary disease in the USA from 1999 to 2010. PloS One. 2014;9(4):e95305. Epub 2014/ 04/23. doi: 10.1371/journal.pone.0095305. PubMed PMID: 24751857; PubMed Central PMCID: PMCPMC3994065.
   Web of Science ®Google Scholar
• Gruffydd-Jones K , Brusselle G , R J , et al. Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: in UK primary care: a real-world, retrospective, observational. NPJ Primary Care Respiratory Med. 2016;26:16002, Epub 2016/ 02/25. doi: 10.1038/npjpcrm.2016.2. PubMed PMID: 28358398; PubMed Central PMCID: PMCPMC5375386
   PubMed Web of Science ®Google Scholar
• Jacobsen R , Ekholm O , Rasmussen NK , et al. Socioeconomic variations in use of prescription medicines for COPD: a register-based study. Respiratory Care. 2016;61(7): 943–949. Epub 2016/ 01/21. doi: 10.4187/respcare.04335. PubMed PMID: 26786740.
   Web of Science ®Google Scholar
• Lopez-Campos JL , Abad Arranz M , Calero Acuna C , et al. Determinants for changing the treatment of COPD: a regression analysis from a clinical audit. Int J Chron Obstruct Pulmon Dis. 2016;11:1171–1178, Epub 2016/06/23. doi: 10.2147/copd.s103614. PubMed PMID: 27330285; PubMed Central PMCID: PMCPMC4898035
   Web of Science ®Google Scholar
• Price D , West D , Brusselle G , et al. Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns. Int J Chron Obstruct Pulmon Dis. 2014;9:889–904, Epub 2014/ 09/12. doi: 10.2147/copd.s62750. PubMed PMID: 25210450; PubMed Central PMCID: PMCPMC4154894
   PubMed Web of Science ®Google Scholar
• Souliotis K , Kani C , Papageorgiou M , et al. Using big data to assess prescribing patterns in greece: the case of chronic obstructive pulmonary disease. PloS One. 2016;11(5): e0154960. Epub 2016/ 05/19. doi: 10.1371/journal.pone.0154960. PubMed PMID: 27191724; PubMed Central PMCID: PMCPMC4871446.
   Web of Science ®Google Scholar
• Sundh J , Stallberg B , Lisspers K , et al. body mass index and quality of life in COPD using the clinical COPD questionnaire. Copd. 2011;8(3): 173–181. Epub 2011/ 04/26. doi: 10.3109/15412555.2011.560130. PubMed PMID: 21513436.
   PubMedGoogle Scholar
• Sundh J , Janson C , Lisspers K , et al. Clinical COPD Questionnaire score (CCQ) and mortality. Int J Chron Obstruct Pulmon Dis. 2012;7: 833–842. Epub 2013/ 01/02. doi: 10.2147/COPD.S38119. PubMed PMID: 23277739; PubMed Central PMCID: PMC3532021.
   PubMed Web of Science ®Google Scholar
• Sundh J , Janson C , Lisspers K , et al. The Dyspnoea, Obstruction, Smoking, Exacerbation (DOSE) index is predictive of mortality in COPD. Prim Care Respir J. 2012;21(3): 295–301. Epub 2012/ 07/13. doi: pcrj-2012-04-0066 [pii]; doi: 10.4104/pcrj.2012.00054. PubMed PMID: 22786813. .
   PubMedGoogle Scholar
• Sundh J , Osterlund EE , Janson C , et al. Management of COPD exacerbations in primary care: a clinical cohort study. Prim Care Respir J. 2013;22(4): 393–399. Epub 2013/ 10/12. doi: pcrj-2013-06-0082 [pii]; doi: 10.4104/pcrj.2013.00087. PubMed PMID: 24114334.
   PubMedGoogle Scholar
• Arne M , Lisspers K , Stallberg B , et al. How often is diagnosis of COPD confirmed with spirometry? Respir Med. 2010;104(4):550–556. Epub 2009/ 11/26. doi: S0954-6111(09)00358-8 [pii]; doi: 10.1016/j.rmed.2009.10.023. PubMed PMID: 19931443.
   PubMed Web of Science ®Google Scholar
• Tashkin DP , Celli B , Senn S , et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359(15):1543–1554. Epub 2008/10/07. doi: NEJMoa0805800 [pii] 10.1056/NEJMoa0805800. PubMed PMID: 18836213.
   PubMed Web of Science ®Google Scholar
• Rodrigo GJ , Price D , Anzueto A , et al. LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2017;12:907–922, Epub 2017/ 04/01. doi: 10.2147/copd.s130482. PubMed PMID: 28360514; PubMed Central PMCID: PMCPMC5364009
   PubMed Web of Science ®Google Scholar
• Agency SMP . Chronic Obstructive Pulmonary Disease (COPD)- treatment recommendation. 2015 [ cited 2015 Oct 16]. Available from: https://lakemedelsverket.se/upload/halso-och-sjukvard/behandlingsrekommendationer/Kroniskt_obstruktiv_lungsjukdom_KOL_behandlingsrekommendation.pdf.
   Google Scholar
• Sundh J , Ekstrom M. Persistent disabling breathlessness in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2016;11: 2805–2812. Epub 2016/ 11/24. doi: 10.2147/copd.s119992. PubMed PMID: 27877034; PubMed Central PMCID: PMCPMC5108478.
   PubMed Web of Science ®Google Scholar
• Vestbo J , Prescott E , Almdal T , et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the copenhagen city heart study. Am J Respir Crit Care Med. 2006;173(1):79–83. Epub 2005/ 12/22. doi: 173/1/79 [pii]; doi: 10.1164/rccm.200505-969OC. PubMed PMID: 16368793.
   PubMed Web of Science ®Google Scholar
• Montes de Oca M , Talamo C , Perez-Padilla R , et al. Use of respiratory medication in five Latin American cities: the PLATINO study. Pulm Pharmacol Ther. 2008;21(5): 788–793. Epub 2008/ 07/16. doi: 10.1016/j.pupt.2008.06.003. PubMed PMID: 18621136.
   Web of Science ®Google Scholar
• Carrasco-Garrido P , De Miguel-Diez J , Rejas-Gutierrez J , et al. Characteristics of chronic obstructive pulmonary disease in Spain from a gender perspective. BMC Pulm Med. 2009;9:2, Epub 2009/ 01/06. doi: 10.1186/1471-2466-9-2. PubMed PMID: 19121205; PubMed Central PMCID: PMCPMC2633274
   PubMedGoogle Scholar
• Sorheim IC , Johannessen A , Gulsvik A , et al. Gender differences in COPD: are women more susceptible to smoking effects than men? Thorax. 2010;65(6): 480–485. Epub 2010/ 06/05. doi: 10.1136/thx.2009.122002. PubMed PMID: 20522842.
   PubMed Web of Science ®Google Scholar
• Lopez-Campos JL , Ruiz-Ramos M , Soriano JB. Mortality trends in chronic obstructive pulmonary disease in Europe, 1994-2010: a joinpoint regression analysis. Lancet Respir Med. 2014;2(1): 54–62. Epub 2014/01/28. doi: 10.1016/s2213-2600(13)70232-7. PubMed PMID: 24461902.
   PubMed Web of Science ®Google Scholar
• Celli B , Vestbo J , Jenkins CR , et al. Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. Am J Respir Crit. 2011;183(3):317–322. Epub 2010/ 09/04. doi: 10.1164/rccm.201004-0665OC. PubMed PMID: 20813884.
   PubMed Web of Science ®Google Scholar
• Molimard M , Raherison C , Lignot S , et al. Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients. Eur Respir J. 2017;49(2):Epub 2017/ 02/10. doi: 10.1183/13993003.01794-2016. PubMed PMID: 28182569.
   PubMed Web of Science ®Google Scholar
• Goodman DE , Israel E , Rosenberg M , et al. The influence of age, diagnosis, and gender on proper use of metered-dose inhalers. Am J Respir Crit Care Med. 1994;150(5 Pt 1): 1256–1261. Epub 1994/ 11/01. doi: 10.1164/ajrccm.150.5.7952549. PubMed PMID: 7952549.
   PubMed Web of Science ®Google Scholar
• Rolnick SJ , Pawloski PA , Hedblom BD , et al. Patient characteristics associated with medication adherence. Clin Med Res. 2013;11(2): 54–65. Epub 2013/ 04/13. doi: 10.3121/cmr.2013.1113. PubMed PMID: 23580788; PubMed Central PMCID: PMCPMC3692389.
   PubMedGoogle Scholar
• Han MK , Postma D , Mannino DM , et al. Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med. 2007;176(12):1179–1184. Epub 2007/ 08/04. doi: 10.1164/rccm.200704-553CC. PubMed PMID: 17673696; PubMed Central PMCID: PMCPMC2720110.
   PubMed Web of Science ®Google Scholar
• Jenkins CR , Chapman KR , Donohue JF , et al. Improving the Management of COPD in Women. Chest. 2017;151(3): 686–696. Epub 2016/ 11/07. doi: 10.1016/j.chest.2016.10.031. PubMed PMID: 27816445.
   PubMed Web of Science ®Google Scholar
• Tsiligianni I , Rodriguez MR , Lisspers K , et al. Call to action: improving primary care for women with COPD. NPJ Primary Care Respiratory Med. 2017;27(1): 11. Epub 2017/ 02/17. doi: 10.1038/s41533-017-0013-2. PubMed PMID: 28202995; PubMed Central PMCID: PMCPMC5434777.
   PubMed Web of Science ®Google Scholar
• Sundh J , Stallberg B , Lisspers K , et al. Comparison of the COPD Assessment Test (CAT) and the Clinical COPD Questionnaire (CCQ) in a Clinical Population. Copd. 2016;13(1):57–65. Epub 2015/ 09/15. doi: 10.3109/15412555.2015.1043426. PubMed PMID: 26367315.
   Google Scholar